In vivo stimulation of angiogenic activity
US6793918B2 · kind B2 · utility
6Cited by
5References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 1, 2001 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Nov 1, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Angiogenesis is stimulated by introducing two replication-deficient adenovirus vectors to the endothelial cells or proximate to the endothelial cells of an organism. The first vector encodes VEGF-B167 or a fragment or conservative substitution thereof, the second vector encodes VEGF-A or VEGF-C, or fragments or conservative substitutions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.